CompletedNot Applicable

Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).

Spain54 participantsStarted 2023-11-10

Plain-language summary

This study aims to analyze the use of non-invasive brain stimulation (tDCS) is beneficial for the treatment of post-stroke fatigue.

Who can participate

Age range

18 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * First stroke within 45 (+-7) days of the ischemic or hemorrhagic episode. * Ability to understand and execute simple instructions * Over 18 years. * Fatigue Scale of fatigue severity with a score greater than or equal to 24 Exclusion Criteria: * A score \> 2 on the modified Rankin Scale (mRS) before the stroke. * Patients with decompensated cardiorespiratory and/or psychiatric pathology. * Comorbidity causing disproportionate fatigue, such as long-term COVID. * Patients who are cancer survivors or who are undergoing cancer treatment. * Patients with a history of epilepsy or who are taking antiepileptic medication. * Patents with major depression.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Fatigue Assessment Scale

Timeframe: Baseline, 1 month post intervention and 3 months post intervention. Reported through study completion, an average of 1 year.

HADS

Timeframe: Baseline, 1 month post intervention and 3 months post intervention. Reported through study completion, an average of 1 year.

Trial details

NCT IDNCT06149897

SponsorHospital Clinic of Barcelona

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-05

View on ClinicalTrials.gov More Stroke trials

Who can participate

Age range

18 Years – 90 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Fatigue Assessment Scale

Timeframe: Baseline, 1 month post intervention and 3 months post intervention. Reported through study completion, an average of 1 year.

HADS

Timeframe: Baseline, 1 month post intervention and 3 months post intervention. Reported through study completion, an average of 1 year.